<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02541968</url>
  </required_header>
  <id_info>
    <org_study_id>OCD F2F vs ICBT</org_study_id>
    <nct_id>NCT02541968</nct_id>
  </id_info>
  <brief_title>Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder</brief_title>
  <official_title>Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder - a Randomized Controlled Non-inferiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <brief_summary>
    <textblock>
      Randomized controlled non-inferiority trial comparing therapist-guided Internet-based&#xD;
      Cognitive behavioral therapy (ICBT), self-guided ICBT, and individual face-to-face (f2f) CBT&#xD;
      for Obsessive-Compulsive Disorder (OCD) in adults.&#xD;
&#xD;
      The primary objective is to evaluate whether ICBT is a non-inferior treatment option compared&#xD;
      to the best possible available treatment for OCD, individual face to face (f2f) CBT. A second&#xD;
      objective is to compare the efficacy of self-guided vs. therapist-guided ICBT. As this&#xD;
      question has cost implications for the health system, a third objective is to carry out a&#xD;
      health economic evaluation of both forms of ICBT, in relation to the gold standard f2f CBT. A&#xD;
      fourth objective is to explore whether ICBT is equally suited for clinic-referred cases&#xD;
      compared to self-referred patients. Finally, a fifth objective is to investigate whether&#xD;
      genetic markers, in combination with clinical variables, can be employed to predict treatment&#xD;
      outcomes with CBT in general.&#xD;
&#xD;
      Research Questions:&#xD;
&#xD;
      Q1: Is therapist-guided internet-based CBT (ICBT) for OCD non-inferior to face-to-face (f2f)&#xD;
      CBT with regard to OCD symptoms, function and quality of life?&#xD;
&#xD;
      Q2: Is entirely self-guided ICBT non-inferior to f2f CBT with regard to OCD symptoms,&#xD;
      function and quality of life?&#xD;
&#xD;
      Q3: Is ICBT a cost-effective treatment, compared to f2f CBT?&#xD;
&#xD;
      Q4: Is there a difference in treatment outcome between self-referred and clinical referred&#xD;
      patients?&#xD;
&#xD;
      Q5: Can clinical variables and genetic markers be useful to predict which patients will&#xD;
      benefit from CBT?&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 3, 2015</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)</measure>
    <time_frame>Change from baseline to treatmentweek 2, 4, 6, 8, 10 , 12, 15 and 3- and 12-month follow-up.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression - Severity (CGI-S)</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Assessment of Functioning (GAF)</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structured Clinical Interview for DSM-5 (SCID-5) obsessive-compulsive and related disorders Structured Clinical Interview for DSM-5 (SCID-5) obsessive-compulsive and related disorders</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
    <description>Diagnostic status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yale-Brown Obsessive-Compulsive Scale - self-rated (Y-BOCS)</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obsessive-Compulsive Inventory - Revised (OCI-R)</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sheehan Disability Scale (SDS)</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Montgomery-Åsberg Depression Rating Scale - self-rated (MADRS-S)</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Euroqol (EQ-5D)</measure>
    <time_frame>Change from baseline to treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression - Improvement (CGI-I)</measure>
    <time_frame>Treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia Severity Index (ISI)</measure>
    <time_frame>Treatmentweek 15, 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment credibility scale</measure>
    <time_frame>Change from baseline to treatmentweek 2.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with treatment scale</measure>
    <time_frame>Treatmentweek 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TiC-P</measure>
    <time_frame>Treatmentweek 0, 15, 3- and 12-month follow-up.</time_frame>
    <description>Self-rated questionnaire on healthcare utilization and productivity losses in patients with a psychiatric disorder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Monitoring Uniform Report Form (SMURF)</measure>
    <time_frame>Treatmentweek 2, 4, 6, 8, 10 , 12, 15 and 3- and 12-month follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient EX/RP Adherence Scale (PEAS)</measure>
    <time_frame>Treatmentweek 6 and 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Working Alliance Inventory - short revised</measure>
    <time_frame>Change from baseline to treatment week 6 and 15</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Obsessive-compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>Face-to-face CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>16 sessions of individual CBT delivered in 14 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Internet-based CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet-based CBT (ICBT) with therapist support (14 weeks).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICBT without therapist support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet-based CBT without therapist support (14 weeks).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive-behavioral therapy (face-to-face)</intervention_name>
    <arm_group_label>Face-to-face CBT</arm_group_label>
    <other_name>CBT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-based Cognitive-behavioral therapy</intervention_name>
    <description>With therapist support</description>
    <arm_group_label>Internet-based CBT</arm_group_label>
    <other_name>ICBT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-based Cognitive-behavioral therapy without therapist support</intervention_name>
    <arm_group_label>ICBT without therapist support</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years of age,&#xD;
&#xD;
          -  Internet access,&#xD;
&#xD;
          -  primary diagnosis of OCD according to the Diagnostic and Statistical Manual of Mental&#xD;
             Disorders, Fifth Edition (DSM-5),&#xD;
&#xD;
          -  Written consent of participation in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other psychological treatment for OCD during the treatment period,&#xD;
&#xD;
          -  Adjustment of concurrent psychotropic medication within the last two months,&#xD;
&#xD;
          -  bipolar disorder,&#xD;
&#xD;
          -  psychosis,&#xD;
&#xD;
          -  alcohol or substance dependence,&#xD;
&#xD;
          -  completed CBT for OCD in the last 12 months,&#xD;
&#xD;
          -  hoarding disorder or OCD with primary hoarding symptoms,&#xD;
&#xD;
          -  suicidal ideation,&#xD;
&#xD;
          -  subjects that lack the ability to read written Swedish or lack the cognitive ability&#xD;
             to assimilate to the written material,&#xD;
&#xD;
          -  Autism spectrum disorder,&#xD;
&#xD;
          -  organic brain disorder.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Rück</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mottagningen för Tvångssyndrom</name>
      <address>
        <city>Huddinge</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://www.internetpsykiatri.se</url>
    <description>Recruitement</description>
  </link>
  <reference>
    <citation>Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljótsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Rück C. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Jul;72(7):659-67. doi: 10.1001/jamapsychiatry.2015.0546.</citation>
    <PMID>25970252</PMID>
  </reference>
  <reference>
    <citation>Andersson E, Steneby S, Karlsson K, Ljótsson B, Hedman E, Enander J, Kaldo V, Andersson G, Lindefors N, Rück C. Long-term efficacy of Internet-based cognitive behavior therapy for obsessive-compulsive disorder with or without booster: a randomized controlled trial. Psychol Med. 2014 Oct;44(13):2877-87. doi: 10.1017/S0033291714000543. Epub 2014 Mar 14.</citation>
    <PMID>25066102</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 24, 2015</study_first_submitted>
  <study_first_submitted_qc>September 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2015</study_first_posted>
  <last_update_submitted>September 29, 2020</last_update_submitted>
  <last_update_submitted_qc>September 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Christian Rück</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

